Everest Organics Limited has expanded its footprint in Research with the opening of its new Research and Development Center at its factory i.e., Aroor, Hyderabad. EOL's new R&D center is a sign of the company's continued commitment to the API's industry and bringing new job opportunities to the local community. "To better address the needs of our pharmaceutical customers, we are not only expanding our capabilities but also increasing our R&D strength to give our customers a complete solution as well as focus on new product development for the growth of the company." said Dr. Sri Kakarlapudi Srihari Raju, Managing Director, Everest Organics Limited.
The Research and Development Center is state of art analytical, quality control and fully-equipped lab with well trained experts in a single facility. The center will accelerate growth of the company's portfolio of innovative technologies and products that overcome shortage in intermediates, process challenges and will provide hands-on support to assist customers in their drug development.
Dr. Sirisha Srikakarlapudi, Director and Head of Regulated Market said "There is a clear market need for a comprehensive set of innovative products and technologies to support existing set of products. At our new center for Research, we can help customers overcome the challenge for small trail quantities and also improve the process which in turn helps in better utilization and cost effectiveness."
Shares of EVEREST ORGANICS LTD. was last trading in BSE at Rs.150.5 as compared to the previous close of Rs. 150.5. The total number of shares traded during the day was 986 in over 33 trades.
The stock hit an intraday high of Rs. 158.75 and intraday low of 146.6. The net turnover during the day was Rs. 148697.